Intraarterial Thrombolysis for Cerebral Infarction:To Treat or Not to Treat, and How?

References

1. ↵
   del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. . Stroke 1998;29:4-11

   Abstract/FREE Full Text
2. ↵
   The National Institute of Neurologic Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. . N Engl J Med 1995;333:1581-1587

   CrossRefPubMedWeb of Science
3. von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. . AJNR Am J Neuroradiol 1994;15:9-15

   Abstract/FREE Full Text
4. ↵
   Fukazawa S. Waki R. Hidaka A. Kishimoto R. et al. Angiographic A-V Shunt during interventional thrombolysis for acute cerebral embolism. A new predictive sign for hemorrhagic complication. . Intervent Neuroradiol 1997;3:75-78